Market Overview - US stock indices collectively rose, with the Dow Jones up 0.65%, Nasdaq up 0.44%, and S&P 500 up 0.59%. Notable tech stocks like Tesla and Intel rose over 4%, while Oracle fell over 2% [5] - International oil prices showed slight fluctuations, with WTI crude oil rising 0.32% to $65.19 per barrel, and Brent crude oil increasing 0.23% to $68.74 per barrel [6] - International precious metals futures generally increased, with COMEX gold futures up 0.50% to $3789.8 per ounce and COMEX silver futures up 2.77% to $46.365 per ounce [5] Corporate Actions - Morgan Stanley increased its stake in Alibaba from 6.81% to 12.29% as of September 22, indicating confidence in Alibaba's future prospects [21] - Xiaomi's legal department reported that it has assisted 35 car owners in legal actions against network attacks, highlighting the company's commitment to consumer rights [19] - Tencent released and open-sourced its new 3D generation models, which may accelerate the application of 3D technology across various industries [26][27] Regulatory Developments - The Chinese government announced the implementation of export license management for pure electric passenger vehicles to promote healthy development in the new energy vehicle trade [11] - The People's Bank of China emphasized the importance of maintaining capital market stability through various financial tools and support for key sectors [7] Industry News - The China Textile Industry Association expressed support for the investigation into Mexico's trade barriers against Chinese products, reflecting the industry's proactive stance on international trade issues [12] - The China Mining Association supported the Ministry of Commerce's investigation into Mexico's trade restrictions, urging affected parties to participate [13]

Market Overview - US stock indices collectively rose, with the Dow Jones up 0.65%, Nasdaq up 0.44%, and S&P 500 up 0.59%. Notable tech stocks like Tesla and Intel rose over 4%, while Oracle fell over 2% [2] - International oil prices showed slight fluctuations, with WTI crude oil rising 0.32% to $65.19 per barrel, and Brent crude oil up 0.23% to $68.74 per barrel, marking weekly increases of 4.47% and 4.10% respectively [3] - European stock indices closed higher, with Germany's DAX up 0.87%, France's CAC40 up 0.97%, and the UK's FTSE 100 up 0.77% [4] Central Bank and Regulatory Actions - The People's Bank of China emphasized the importance of maintaining capital market stability and supporting sectors like technology innovation and small businesses through various monetary policy tools [5] - The Chinese government announced export license management for pure electric passenger vehicles to promote healthy development in the new energy vehicle trade [9] - The China Securities Regulatory Commission and other departments are enhancing support for foreign institutional investors in the bond repurchase market [9] Corporate Developments - Morgan Stanley increased its stake in Alibaba from 6.81% to 12.29% as of September 22, indicating confidence in Alibaba's future prospects [20] - Xiaomi's legal department reported on its efforts to assist car owners facing network attacks, having initiated 35 lawsuits to protect consumer rights [17] - Zero Run Auto was listed as a dishonest executor due to a debt of 3.618 million yuan owed by its subsidiary [21] Technology and Innovation - Moore Threads' IPO application was approved in just 88 days, reflecting improved efficiency in the review process for technology companies on the STAR Market [16] - Tencent released and open-sourced new 3D generation models, aiming to accelerate the application of 3D technology in various industries [26] Legal and Regulatory Challenges - Apple requested the EU to abolish the Digital Markets Act, facing a strong response from the EU Commission [23] - The Hong Kong High Court rejected a legal appeal from宗馥莉 regarding a disclosure order, while allowing a temporary stay for further appeal [19]

Core Viewpoint - The Shanghai Stock Exchange (SSE) is actively engaging with investment institutions to enhance the implementation of the "1+6" policy measures for the Sci-Tech Innovation Board, aiming to improve the attractiveness and inclusivity of the capital market [1] Group 1 - SSE organized a 2025 equity investment institution exchange meeting with 38 equity investment institutions and 12 sponsoring institutions to gather market feedback and address concerns [1] - The SSE plans to study and incorporate the opinions and suggestions from market institutions to further promote the "open-door" approach in review, supervision, and services [1] - The meeting highlighted the need for support in IPOs and mergers and acquisitions for hard technology companies, as well as enhancing the inclusivity and stability of expectations for the Sci-Tech Innovation Board [1] Group 2 - Suggestions from participating institutions included optimizing pricing mechanisms and facilitating orderly participation of long-term funds in the construction of the Sci-Tech Innovation Board [1] - There is a call for collaborative efforts in nurturing technology enterprises and strengthening information sharing and communication among institutions [1]

Group 1 - The core focus of the Shanghai Stock Exchange (SSE) is to implement the "1+6" policy measures for the Sci-Tech Innovation Board, enhancing the attractiveness and inclusivity of the capital market [1] - SSE organized a communication meeting with 38 private equity institutions and 12 sponsoring institutions to gather market feedback and address concerns [1] - The SSE aims to establish a regular communication mechanism with market institutions to better facilitate the implementation of the "1+6" policy and create a favorable capital market ecosystem [1] Group 2 - Participating institutions acknowledged the achievements of the Sci-Tech Innovation Board reforms while suggesting improvements in areas such as supporting hard-tech companies for IPOs and mergers, enhancing inclusivity and stability, and optimizing pricing mechanisms [1] - Recommendations included promoting orderly participation of long-term capital in the construction of the Sci-Tech Innovation Board and collaborating on the cultivation of technology enterprises [1] - Institutions emphasized the importance of strengthening information sharing and communication among stakeholders [1]

Core Viewpoint - The Shanghai Stock Exchange (SSE) held a conference to discuss the implementation of the "1+6" policy measures for the Sci-Tech Innovation Board, aiming to enhance the attractiveness and inclusivity of the capital market [1] Group 1: Conference Details - The SSE organized the 2025 equity investment institution exchange meeting, engaging with 38 equity investment institutions and 12 sponsoring institutions [1] - The conference focused on gathering market demands and responding to market concerns regarding the Sci-Tech Innovation Board [1] Group 2: Feedback and Suggestions - Participating institutions acknowledged the achievements of the Sci-Tech Innovation Board reforms and provided multiple suggestions, including support for hard technology companies' IPOs and mergers and acquisitions [1] - Recommendations also included enhancing the inclusivity and stability of expectations for the Sci-Tech Innovation Board, optimizing pricing mechanisms, and promoting orderly participation of medium- and long-term funds [1] Group 3: Future Actions - The SSE committed to studying and incorporating the feedback from market institutions to further advance the implementation of the "1+6" policy [1] - The SSE aims to improve communication mechanisms with market institutions and foster a better capital market ecosystem to support high-level technological self-reliance [1]

Group 1 - The Shanghai Stock Exchange (SSE) organized a conference focusing on the implementation of the "1+6" policy measures for the Sci-Tech Innovation Board, aiming to enhance the attractiveness and inclusiveness of the capital market [1] - The conference involved in-depth discussions with 38 private equity institutions and 12 sponsoring institutions, addressing market demands and concerns [1] - Participants acknowledged the achievements of the Sci-Tech Innovation Board reforms and provided multiple suggestions, including support for hard technology companies' IPOs and mergers, improving inclusiveness and stability, optimizing pricing mechanisms, and promoting orderly participation of long-term funds [1] Group 2 - The SSE plans to carefully study and incorporate the feedback from market institutions to further advance the implementation of the "1+6" policy [1] - There is a commitment to enhance regular communication and interaction mechanisms with market institutions to better facilitate the reforms of the Sci-Tech Innovation Board [1] - The overall goal is to create a favorable capital market ecosystem that better serves high-level technological self-reliance and strength [1]

Core Viewpoint - The approval of Moer Thread's IPO application by the Shanghai Stock Exchange demonstrates the enhanced efficiency of the Sci-Tech Innovation Board's review process following the implementation of the "1+6" reform policy by the China Securities Regulatory Commission [1] Group 1 - Moer Thread's IPO application was approved in just 88 days from acceptance to review [1] - The approval coincides with the 100th day since the announcement of the "1+6" reform policy, indicating a significant improvement in the review quality and efficiency for Sci-Tech Innovation Board projects [1] - The acceleration of IPO projects for hard technology companies reflects a broader trend of increased inclusivity and adaptability in current policies [1]

Core Viewpoint - The issuance of new registered companies in the Sci-Tech Innovation Growth Layer is ready, with Wuhan Heyuan Biotechnology Co., Ltd. initiating its issuance, marking a significant step in the "1+6" reform of the Sci-Tech Innovation Board [1][3]. Group 1: Company Overview - Heyuan Biotechnology is the first company to start the issuance process after the resumption of the fifth set of standards for the Sci-Tech Innovation Board [4]. - The company has developed a globally pioneering "rice-derived blood" technology, supported by the national "Major New Drug Creation" program [4]. - Heyuan's self-developed innovative drug, recombinant human albumin injection (from rice), was approved for market launch in July, aiming to reduce China's long-term reliance on imported human serum albumin [4]. Group 2: Market Context - The issuance of Heyuan Biotechnology reflects the implementation of the "1+6" reform, enhancing the system's inclusiveness and adaptability for high-quality technology enterprises [4]. - The company is the first to adopt differentiated lock-up and allocation arrangements for offline issuance, with a minimum lock-up ratio of 40% for offline investors [4]. - The Shanghai Stock Exchange has revised its issuance and underwriting rules, allowing unprofitable companies to use agreed lock-up methods, encouraging professional institutions to play a larger role in new stock pricing [5]. Group 3: Industry Developments - Since the announcement of the "1+6" reform policy in June, 15 companies have applied for IPOs on the Sci-Tech Innovation Board, including four unprofitable companies [6]. - Three unprofitable companies have already received IPO registration approval, with two of them under the fifth set of standards [7]. - The Shanghai Stock Exchange has completed system tests for the new registered companies in the Sci-Tech Innovation Growth Layer, with 5 million investors having opened trading permissions for this layer [7].

禾元生物成为科创成长层新注册企业中首家启动发行工作的企业。 9月22日晚，武汉禾元生物科技股份有限公司（简称"禾元生物"）在上交所网站披露招股意向书、发行 安排及初步询价公告，正式启动发行工作。这意味着，禾元生物将成为科创成长层新注册企业中首家启 动发行工作的企业。 禾元生物启动发行，是落实科创板"1+6"改革、增强对优质科技型企业的制度包容性和适应性的重要体 现，彰显了尊重科技创新规律、支持优质科技企业发展、更好服务新质生产力的政策导向。 值得一提的是，根据"科创板八条"的相关试点安排，禾元生物也是首家采用网下发行差异化限售与配售 安排的公司。根据禾元生物披露的公告文件，其网下整体限售比例不低于40%，对投资者报价设置了3 档差异化限售档位，申购最高限售档位投资者的配售比例不低于最低限售档位的9倍。 市场人士指出，今年3月上交所修订发行承销业务规则，明确未盈利企业可以采用约定限售方式，网下 投资者自愿报价申购，履行限售更高比例、更长期限的承诺和义务并相应获配较多的新股，鼓励更 多"看得准、拿得住"的专业机构在新股发行定价中发挥更大作用，促进新股合理定价。 今年以来，上交所持续推进"科创板八条"和科创板"1+ ...

自今年6月科创板"1+6"改革政策以来，科创板新增受理15家公司IPO申请，其中4家为未盈利企业，1家 适用第五套标准。目前，已有3家未盈利企业IPO注册生效，其中2家为第五套标准企业。禾元生物也是 重启科创板第五套标准后的首家过会并取得注册批文的企业。 证券时报记者获悉，目前，科创成长层首批新注册企业发行上市的各项工作正在有序稳步推进中，上交 所技术系统完成全网通关测试，已于近日陆续上线。证券公司已有序组织投资者签署参与科创成长层交 易的风险揭示书，目前已有500万户投资者开通科创成长层交易权限。 禾元生物启动发行，是落实科创板"1+6"改革、增强对优质科技型企业的制度包容性和适应性的重要体 现，彰显了尊重科技创新规律、支持优质科技企业发展、更好服务新质生产力的政策导向。 值得一提的是，根据"科创板八条"的相关试点安排，禾元生物也是首家采用网下发行差异化限售与配售 安排的公司。根据禾元生物披露的公告文件，其网下整体限售比例不低于40%，对投资者报价设置了3 档差异化限售档位，申购最高限售档位投资者的配售比例不低于最低限售档位的9倍。 禾元生物成为科创成长层新注册企业中首家启动发行工作的企业。 9月22日晚， ...